Anvisa analyzes the emergency use of a new vaccine against covid-19
An Emergency Use Authorization request for the version of the bivalent vaccine against covid-19, developed by the pharmaceutical company Moderna ...
An Emergency Use Authorization request for the version of the bivalent vaccine against covid-19, developed by the pharmaceutical company Moderna ...
The governor of São Paulo, Tarcísio de Freitas, sanctioned the bill that prohibits the requirement of proof of vaccination against ...
The Minister of Health, Nísia Trindade, said today (6) that the new rules for accessing the Bolsa Família bring a ...
Those who are going to enjoy the extended Carnival holiday in São Paulo cities that are on the border with ...
The Ministry of Health intends to start applying booster doses with the bivalent vaccine to immunize against covid-19 from the ...
The National Health Surveillance Agency (Anvisa) decided to extend the validity period of the Comirnaty vaccine, a monovalent vaccine against ...
Children aged 5 to 11 years, residents of the city of Rio de Janeiro, can now receive a booster dose ...
The World Health Organization (WHO) has updated recommendations for the vaccine against HPV, one of the main risk factors for ...
With an investment of R$ 80 million, divided into R$ 50 million of federal resources, coming from the National Fund ...
The dengue vaccine developed by the Butantan Institute was 79.6% effective in clinical trials. According to the institution, follow-up with ...
Folha Nobre - Desde 2013 - ©